Rational Therapeutics Release: Targeted Cancer Therapy Improved with Ex-Vivo Chemosensitivity Analysis

Published: Jun 01, 2007

LONG BEACH, Calif. & CHICAGO--(BUSINESS WIRE)--Researchers at Rational Therapeutics (Long Beach, Calif.) www.rationaltherapeutics.com have reported clinical results obtained with a laboratory technique (Ex-Vivo Analysis of Programmed Cell Death – EVA-PCD™) that accurately identifies patients who are candidates for targeted cancer therapy.

Back to news